Abbott Picks Spinal Concepts As Market Entry; InFix Device Approval Awaited
This article was originally published in The Gray Sheet
Executive Summary
Abbott Labs' entry into the orthopedics market through the $170 mil. purchase of Spinal Concepts mirrors its cardiovascular devices business strategy, according to the firm